Swipe om te navigeren naar een ander artikel
The goal of this study was to analyze health-related quality of life (HRQL) data from a Canadian population with type 2 diabetes in order to estimate the disutility associated with experiencing a diabetes-related complication.
The EQ-5D, a standardized instrument for use as a measure of health outcome, was administered to 1,147 patients in Hamilton, Ontario, with type 2 diabetes. After controlling for age, gender, and duration of diabetes, changes in utility values were estimated by regressing the EQ-5D scores onto binary indicators for the presence of an event. The primary method of analysis was Ordinary Least Squares (OLS) and due to concerns over non-Normality, bootstrap standard errors (SE) were calculated.
The analysis included 1,143 participants. Based on the OLS model, reductions in HRQL were associated with duration of diabetes (−0.0015, SE = 0.0006), experiencing a myocardial infarction (MI) (−0.059, SE = 0.017), amputation (−0.063, SE = 0.059), stroke (−0.046, SE = 0.023), and kidney failure (−0.102, SE = 0.047).
This study estimated the reductions in HRQL associated with several important complications commonly experienced in patients with diabetes. The greatest impacts on HRQL were associated with kidney failure and MI. The utility values calculated here can be used to assess the outcome of interventions that reduce these diabetes-related complications and will have a useful impact on future economic evaluations of diabetes management strategies in Canada.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Canadian Diabetes Association (2009). An economic tsunami: The cost of diabetes in Canada. Available: URL: http://www.diabetes.ca/economicreport/. Accessed 5 Sept 2010.
Grundy, S. M., Benjamin, I. J., Burke, G. L., Chait, A., Eckel, R. H., Howard, B. V., et al. (1999). Diabetes and cardiovascular disease: A statement for healthcare professionals from the American heart association. Circulation, 100(10), 1134–1146. PubMed
Clarke, P., Gray, A., & Holman, R. (2002). Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Medical Decision Making, 22(4), 340–349. PubMed
Holmes, J., Mcgill, S., Kind, P., Bottomley, J., Gillam, S., & Murhpy, M. (2000). Health-related quality of life in type 2 diabetes. Value Health, 3(Suppl 1), S47–S51. CrossRef
Koopmanschap, M. (2002). Coping with type II diabetes: The patient’s perspective. Diabetologia, 45(7), S18–S22. PubMed
MacKeigan, L. D., & Pathak, D. S. (1992). Overview of health-related quality-of-life measures. American Journal of Hospital Pharmacy, 49(9), 2236–2245. PubMed
Feeny, D., Barr, R. D., Furlong, W., et al. (1991). Quality of life of the treatment process in pediatric oncology: An approach to measurement. In D. Osaba (Ed.), Effect of cancer on quality of life. Boca Raton, FL: CRC Press.
The Diabetes Control and Complications Trial Research Group (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine, 329(14), 977–986. CrossRef
Diabetes Hamilton (2010). Diabetes Hamilton. Available from: URL: http://www.diabeteshamilton.ca/ndefault.php.
Grandy, S., & Fox, K. M. (2008). EQ-5D visual analog scale and utility index values in individuals with diabetes and at risk for diabetes: Findings from the study to help improve early evaluation and management of risk factors leading to diabetes (SHIELD). Health Qual Life Outcomes, 6, 18. PubMedCrossRef
National Institute for Clinical Excellence (2004). Guide to the methods of technology appraisal. London: National Institute for Clinical Excellence.
- Estimation of the impact of diabetes-related complications on health utilities for patients with type 2 diabetes in Ontario, Canada
Daria J. O’Reilly
Hertzel C. Gerstein
Gord K. Blackhouse
Ron A. Goeree
- Springer Netherlands